Coronaviruses belong to a large family of viruses that potentially cause many illnesses in animals or humans. In humans, coronaviruses are known to cause respiratory infections ranging from common colds to more severe diseases such as Middle East respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The recently discovered novel coronavirus SARS-Cov-2, causing COVID-19, certainly gained significance worldwide over the last year. TheCOVID-19 test kits offered by Labex are RT PCR, Flu/COVID-19 RT PCR diagnosis, and rapid antigen and antibody testing.
SARS-CoV-2 RT-PCR Test Kit
Rapid identification of infected people helps to limit the spread of the virus and to cope with the disease. The standard method of COVID-19 diagnosis is by Reverse Transcription Polymerase Chain Reaction (RT-PCR) from nasal and nasopharyngeal swabs. Our Novel Coronavirus Real Time PCR Kit offers quick and reliable detection of this infectious agent without the need to perform RNA extraction.
Rapid IgG/IgM Test Kit
The COVID-19 IgG/IgM Rapid Test is intended for qualitative, in vitro detection of IgG and IgM antibodies to the novel coronavirus in human serum, plasma, or whole blood. The test can be used as a supplementary indicator in cases with negative RT-PCR results or in coordination with RT-PCR testing to check the exposure of the individuals to the virus in the recent past.
Antigen Rapid Test Kit
The COVID-19 Antigen Rapid Test is intended for the qualitative detection of the SARS-CoV-2 virus in individuals who are suspected of COVID-19 disease. The test is also recommended for asymptomatic individuals with suspected COVID-19 disease or to evaluate the COVID-19 epidemiological situation. The Test is done on the samples obtained from the nose or nasopharyngeal region. Test results can be obtained within 3-15 minutes.
Vaccine IgG Rapid Test
The COVID-19 Vaccine IgG Rapid Test is a lateral flow immunoassay intended for the qualitative detection of antibodies binding to the Receptor Binding Domain (RBD) of the spike protein of the SARS-CoV-2 virus or COVID-19 vaccine in human serum, plasma, or whole blood. The kit is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, or as an aid in assessing the immune response of individuals that have been previously immunized with a COVID-19 vaccine.
